Steve D. Wilton

4th Floor A Block, Verdun Street
Nedlands, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression.

Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression.

Journal: Molecular therapy. Nucleic acids

Published: June 04, 2026

A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3.

A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3.

Journal: Acta neuropathologica

Published: March 29, 2026

Skipping of Duplicated Dystrophin Exons: In Vitro Induction and Assessment.

Skipping of Duplicated Dystrophin Exons: In Vitro Induction and Assessment.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 28, 2025

Discovery of Novel APOC3 Isoforms in Hepatic and Intestinal Cell Models Using Long-Read RNA Sequencing.

Discovery of Novel APOC3 Isoforms in Hepatic and Intestinal Cell Models Using Long-Read RNA Sequencing.

Journal: Genes

Published: March 14, 2025

Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T.

Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T.

Journal: Brain : a journal of neurology

Published: October 03, 2024

Risk factors associated with surgical site infection following orthopaedic surgery in South Africa and Sub-Saharan Africa: a scoping review protocol.

Risk factors associated with surgical site infection following orthopaedic surgery in South Africa and Sub-Saharan Africa: a scoping review protocol.

Journal: Journal of wound care

Published: August 14, 2024

Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?

Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?

Journal: International journal of molecular sciences

Published: July 01, 2024

Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis.

Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis.

Journal: International journal of molecular sciences

Published: June 28, 2024

Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.

Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.

Journal: International journal of molecular sciences

Published: April 18, 2024

Antisense oligonucleotides and their applications in rare neurological diseases.

Antisense oligonucleotides and their applications in rare neurological diseases.

Journal: Frontiers in neuroscience

Published: April 09, 2024

The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy.

The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy.

Journal: medRxiv : the preprint server for health sciences

Published: April 08, 2024

A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease.

A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: March 05, 2024

Showing 1-12 of 96

Last Updated: 09/26/2026